The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 2 of 9
Back to Result List

Mitochondrial effects of common cardiovascular medications: the good, the bad and the mixed

Please always quote using this URN: urn:nbn:de:bvb:20-opus-297384
  • Mitochondria are central organelles in the homeostasis of the cardiovascular system via the integration of several physiological processes, such as ATP generation via oxidative phosphorylation, synthesis/exchange of metabolites, calcium sequestration, reactive oxygen species (ROS) production/buffering and control of cellular survival/death. Mitochondrial impairment has been widely recognized as a central pathomechanism of almost all cardiovascular diseases, rendering these organelles important therapeutic targets. Mitochondrial dysfunction hasMitochondria are central organelles in the homeostasis of the cardiovascular system via the integration of several physiological processes, such as ATP generation via oxidative phosphorylation, synthesis/exchange of metabolites, calcium sequestration, reactive oxygen species (ROS) production/buffering and control of cellular survival/death. Mitochondrial impairment has been widely recognized as a central pathomechanism of almost all cardiovascular diseases, rendering these organelles important therapeutic targets. Mitochondrial dysfunction has been reported to occur in the setting of drug-induced toxicity in several tissues and organs, including the heart. Members of the drug classes currently used in the therapeutics of cardiovascular pathologies have been reported to both support and undermine mitochondrial function. For the latter case, mitochondrial toxicity is the consequence of drug interference (direct or off-target effects) with mitochondrial respiration/energy conversion, DNA replication, ROS production and detoxification, cell death signaling and mitochondrial dynamics. The present narrative review aims to summarize the beneficial and deleterious mitochondrial effects of common cardiovascular medications as described in various experimental models and identify those for which evidence for both types of effects is available in the literature.show moreshow less

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar Statistics
Metadaten
Author: Alina M. Bețiu, Lavinia Noveanu, Iasmina M. Hâncu, Ana Lascu, Lucian Petrescu, Christoph Maack, Eskil Elmér, Danina M. Muntean
URN:urn:nbn:de:bvb:20-opus-297384
Document Type:Journal article
Faculties:Medizinische Fakultät / Medizinische Klinik und Poliklinik I
Medizinische Fakultät / Deutsches Zentrum für Herzinsuffizienz (DZHI)
Language:English
Parent Title (English):International Journal of Molecular Sciences
ISSN:1422-0067
Year of Completion:2022
Volume:23
Issue:21
Article Number:13653
Source:International Journal of Molecular Sciences (2022) 23:21, 13653. https://doi.org/10.3390/ijms232113653
DOI:https://doi.org/10.3390/ijms232113653
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Tag:adverse effects; cardiovascular drugs; drug interaction; drug intoxication; drug toxicity; lactic acidosis; mitochondria function and morphology
Release Date:2023/10/18
Date of first Publication:2022/11/07
Licence (German):License LogoCC BY: Creative-Commons-Lizenz: Namensnennung 4.0 International